Estrella Immunopharma Inc. (ESLA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $22.36M
Last updated: Nov 17, 2026 at 11:05 AM ET
Estrella Immunopharma Inc. (ESLA) Earnings: Report Dates and Results
Estrella Immunopharma (ESLA) is expected to report earnings on Mar 16, 2027. In the quarter ended Sep 30, 2026, Estrella Immunopharma reported EPS of -$0.17, below the -$0.08 estimate. It beat the EPS estimate in 5 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
ESLA has an expected report date of Mar 16, 2027.
Earnings History
Of the 9 quarters below that had an estimate, ESLA beat 6 and missed 3. The widest gap in the table came in the quarter ended Sep 30, 2026, when EPS landed 112.50% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported |
|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.17 | -$0.08 | -$0.08 - -$0.08 | -112.50% | Miss | N/A | 1 | 1 up, 0 down | Nov 13, 2026 |
| Jun 30, 2026 | -$0.05 | -$0.09 | -$0.09 - -$0.09 | +44.44% | Beat | N/A | 1 | 1 up, 0 down | Aug 13, 2026 |
| Mar 31, 2026 | -$0.05 | -$0.19 | N/A | +73.68% | Beat | N/A | 1 | 1 up, 0 down | May 15, 2026 |
| Dec 31, 2025 | -$0.01 | -$0.07 | -$0.07 - -$0.07 | +85.71% | Beat | N/A | 1 | 0 up, 0 down | Mar 18, 2026 |
| Sep 30, 2025 | -$0.13 | -$0.07 | -$0.07 - -$0.07 | -85.71% | Miss | N/A | 1 | 0 up, 0 down | Nov 12, 2025 |
| Jun 30, 2025 | -$0.15 | -$0.12 | N/A | -25.00% | Miss | N/A | 1 | 0 up, 0 down | Aug 11, 2025 |
| Mar 31, 2025 | -$0.06 | -$0.11 | -$0.11 - -$0.11 | +45.45% | Beat | N/A | 1 | 0 up, 0 down | May 14, 2025 |
| Dec 31, 2024 | -$0.03 | -$0.12 | N/A | +75.00% | Beat | N/A | N/A | N/A | Feb 15, 2025 |
| Sep 30, 2024 | -$0.09 | -$0.12 | N/A | +25.00% | Beat | N/A | N/A | N/A | Nov 14, 2024 |
| Jun 30, 2024 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 27, 2024 |
| Mar 31, 2024 | -$0.01 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 14, 2024 |
| Dec 31, 2023 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Feb 14, 2024 |
| Sep 30, 2023 | -$1.78 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 30, 2023 |
| Jun 30, 2023 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 30, 2023 |
| Mar 31, 2023 | -$0.03 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 28, 2023 |
| Dec 31, 2022 | -$0.11 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 29, 2023 |
| Sep 30, 2022 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 14, 2022 |
| Jun 30, 2022 | -$0.06 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 28, 2022 |
| Mar 31, 2022 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2022 |
| Dec 31, 2021 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 30, 2022 |
| Sep 30, 2021 | -$0.02 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 10, 2021 |
| Jun 30, 2021 | Not reported | N/A | N/A | N/A | Not reported | N/A | N/A | N/A | Sep 28, 2021 |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.35, after -$0.24 the year before. It was -$0.14 for the year ended Dec 31, 2021, the oldest of the 5 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.35 | N/A |
| Dec 31, 2024 | -$0.24 | N/A |
| Dec 31, 2023 | -$1.87 | N/A |
| Dec 31, 2022 | -$0.25 | N/A |
| Dec 31, 2021 | -$0.14 | N/A |
Frequently Asked Questions About ESLA
When is Estrella Immunopharma's next earnings date?
Estrella Immunopharma's next earnings report is expected for Mar 16, 2027.
Did ESLA beat earnings estimates last quarter?
No. Estrella Immunopharma reported EPS of -$0.17 for the quarter ended Sep 30, 2026, below the -$0.08 estimate by 112.50%.
What EPS do analysts expect from ESLA next quarter?
The consensus EPS estimate for Estrella Immunopharma for the quarter ending Dec 31, 2026 is -$0.07 from 3 analysts, with estimates from -$0.07 to -$0.07.
How often does ESLA beat earnings estimates?
Estrella Immunopharma beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +12.64%.
ESLA pages: Overview, Earnings, Forecast, Financials, Competitors